Podchaser Logo
Home
Ep 2. Gemma Peters, CEO Blood Cancer UK (Part 2): Implications of Black Lives Matter - What does Diversity, Equity and Inclusion really mean?

Ep 2. Gemma Peters, CEO Blood Cancer UK (Part 2): Implications of Black Lives Matter - What does Diversity, Equity and Inclusion really mean?

Released Monday, 24th August 2020
 1 person rated this episode
Ep 2. Gemma Peters, CEO Blood Cancer UK (Part 2): Implications of Black Lives Matter - What does Diversity, Equity and Inclusion really mean?

Ep 2. Gemma Peters, CEO Blood Cancer UK (Part 2): Implications of Black Lives Matter - What does Diversity, Equity and Inclusion really mean?

Ep 2. Gemma Peters, CEO Blood Cancer UK (Part 2): Implications of Black Lives Matter - What does Diversity, Equity and Inclusion really mean?

Ep 2. Gemma Peters, CEO Blood Cancer UK (Part 2): Implications of Black Lives Matter - What does Diversity, Equity and Inclusion really mean?

Monday, 24th August 2020
 1 person rated this episode
Rate Episode

“It cannot possibly be true that we have the best scientists working on blood cancer, if that scientific community only represents one bit of the population.”

In Part 2 of our conversation with Gemma Peters, CEO of Blood Cancer UK, we delve in to what Diversity, Equity and Inclusion really means for the charity sector. Gemma shares the responsibility she feels being a white leader, with an all-white Board, Executive Team and with predominantly white scientific researchers. We look at specific initiatives that Blood Cancer UK are pursuing to address this and how, as a sector, we can look to disestablish racist structures and precedents.

Gemma reveals that the true inspiration and drive for the work comes from the people she and her organisation are striving to help.

Show More

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features